In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

But the company is not ruling out future deals, even in its metabolic unit, which recently saw a major partnership with ...

Roche details plans to handle US tariffs, including moving production and building inventory, while Sanofi runs scenarios but ...

Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...

Big Pharma's M&A plans will likely take a hit if the U.S. government under the Trump administration lives up to its threats ...

The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...

Switzerland’s top officials are expected to determine whether big commitments to the U.S. can help secure relief from Trump’s ...

Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, whose array of ...

Roche, in collaboration with Universitätsklinikum Heidelberg, has developed a Chest Pain Triage algorithm - a CE-marked IVD medical device1 set to transform cardiac careThis novel algorithm offers a s ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...